Annual report 2022

33 Major Subsidiaries 

 

 

Subsidiary

 

Equity participation

 

Registered capital (including paid-in capital in the USA)

 

Direct participation by medmix Ltd

 

Research and development

 

Production and engineering

 

Sales

 

Service

Europe

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Switzerland

 

medmix Switzerland AG, Haag

 

100%

 

CHF 100’000

 

 

 

 

 

 

 

 

 

medmix Group AG, Baar

 

100%

 

CHF 100’000

 

 

 

 

 

 

 

 

 

Germany

 

medmix Deutschland Holding GmbH, Bechhofen

 

100%

 

EUR 870’000

 

 

 

 

 

 

 

 

 

 

 

 

GEKA GmbH, Bechhofen

 

100%

 

EUR 878’600

 

 

 

 

 

 

 

 

medmix Deutschland GmbH, Kiel

 

100%

 

EUR 26’000

 

 

 

 

 

 

 

 

Haselmeier GmbH, Stuttgart

 

100%

 

EUR 2’027’700

 

 

 

 

 

 

 

Spain

 

medmix Spain S.L. 1)

 

100%

 

EUR 3’600

 

 

 

 

 

 

 

 

UK

 

medmix UK Ltd., Hungerford

 

100%

 

GBP 1’000’000

 

 

 

 

 

 

 

 

North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

USA

 

medmix US Inc., Salem, New Hampshire

 

100%

 

USD 0

 

 

 

 

 

 

 

 

 

 

 

GEKA Manufacturing Corporation, Elgin, Illinois

 

100%

 

USD 603’719

 

 

 

 

 

 

 

 

 

medmix US Holding Inc., Salem, New Hampshire

 

100%

 

USD 1’000

 

 

 

 

 

 

 

 

 

 

Central and South America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brazil

 

GEKA do Brasil Indústria e Comércio de Embalagens Ltda., Cotia

 

100%

 

BRL 15’009’794

 

 

 

 

 

 

 

Asia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

India

 

Haselmeier India Pvt. Ltd., Bengaluru

 

100%

 

INR 32’309’720

 

 

 

 

 

 

 

 

 

People’s Republic of China

 

medmix China Ltd., Shanghai

 

100%

 

CHF 1’000’000

 

 

 

 

 

 

 

 

 

1) Acquired in 2022.